11-2777002-G-C
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PS1PM1PM2PM5PP3_StrongPP5_Moderate
The NM_000218.3(KCNQ1):c.1702G>C(p.Gly568Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another nucleotide change resulting in same amino acid change has been previously reported as Pathogenicin Lovd. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G568A) has been classified as Pathogenic.
Frequency
Consequence
NM_000218.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNQ1 | NM_000218.3 | c.1702G>C | p.Gly568Arg | missense_variant | 14/16 | ENST00000155840.12 | NP_000209.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNQ1 | ENST00000155840.12 | c.1702G>C | p.Gly568Arg | missense_variant | 14/16 | 1 | NM_000218.3 | ENSP00000155840 | P1 | |
KCNQ1 | ENST00000335475.6 | c.1321G>C | p.Gly441Arg | missense_variant | 14/16 | 1 | ENSP00000334497 | |||
KCNQ1 | ENST00000496887.7 | c.1345G>C | p.Gly449Arg | missense_variant | 14/16 | 5 | ENSP00000434560 | |||
KCNQ1 | ENST00000646564.2 | c.1162G>C | p.Gly388Arg | missense_variant | 9/11 | ENSP00000495806 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Long QT syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 20, 2018 | This sequence change replaces glycine with arginine at codon 568 of the KCNQ1 protein (p.Gly568Arg). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and arginine. This variant is not present in population databases (ExAC no frequency). This variant has been reported to segregate with long QT syndrome in a family and has been reported in individuals with this condition (PMID: 23392653, 22456477). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Other missense substitutions at this codon (p.Gly568Glu and p.Gly568Ala) have been reported in individuals affected with long QT syndrome (PMID: 27041096, 12702160). A different variant (c.1702G>A) giving rise to the same protein effect observed here (p.Gly568Arg) has been reported in an individual affected with long QT syndrome (PMID: 22956155). This suggests that the glycine residue is critical for KCNQ1 protein function. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at